Northwest Biotherapeutics Inc's Comment on Supply Chain
The company depends on manufacturing arrangements that may lead to increased costs and potential delays. Its Sawston facility serves as a primary production site, and any issues there could require establishing new production agreements, which may be difficult to obtain or unfavorable. Manufacturing DCVax product candidates involves complex processes that require specialized facilities, trained personnel, long lead times for equipment and training, and regulatory approvals. Alternative production capacity may not be readily accessible. Scaling up manufacturing for commercialization poses challenges, as neither the company nor its contract manufacturers have prior experience with such scale-up. The personalized nature of DCVax products, which consist of living cells, adds further complexity. Dendreon Corporation is cited as an example of a company that encountered difficulties scaling up manufacturing for its Provenge product.
Northwest Biotherapeutics Inc's Comment on Supply Chain
The company depends on manufacturing arrangements that may lead to increased costs and potential delays. Its Sawston facility serves as a primary production site, and any issues there could require establishing new production agreements, which may be difficult to obtain or unfavorable. Manufacturing DCVax product candidates involves complex processes that require specialized facilities, trained personnel, long lead times for equipment and training, and regulatory approvals. Alternative production capacity may not be readily accessible. Scaling up manufacturing for commercialization poses challenges, as neither the company nor its contract manufacturers have prior experience with such scale-up. The personalized nature of DCVax products, which consist of living cells, adds further complexity. Dendreon Corporation is cited as an example of a company that encountered difficulties scaling up manufacturing for its Provenge product.
Sources:
Northwest Biotherapeutics Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Northwest Biotherapeutics Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
